Together, these mouse models demonstrate that FD bone lesions can develop from activating mutations at the Gs-GPCR level as well as from transgenic expression or knock-in expression of a GNAS allele carrying the R201C or R201H activating mutation. Here, GNAS is linked to Fabry disease.